特鲁伊斯金融公司(Truist Finance)将Astrana Health的存货目标降至46美元, Astrana Health's stock target was lowered to $46 by Truist Financial, despite a Q1 earnings miss.

Astrana Health的股票价格目标降至46.00美元, 但仍保持“买入”评级, Truist Financial lowered Astrana Health's stock price target to $46.00 but maintained a "buy" rating, indicating a potential 48.84% upside. Astrana Health报告,每份(0.15美元)的Q1收入为每份(3.7美元),缺失的估计数为每份(0.15美元),收入为6.6521亿美元。 Astrana Health reported Q1 earnings per share of ($0.15), missing estimates by ($0.37), with revenue of $665.21 million. 尽管最近短期利息下降,但该公司的股票有一致的“机动购买”评级,目标价格为56.17美元。 Despite a recent decline in short interest, the company's stock has a consensus "Moderate Buy" rating and a target price of $56.17.